Laser-assisted phototherapy clears AK in immunocompromised patients

05/28/2013 | SkinAndAllergyNews.com

Intensified ablative fractional laser-assisted photodynamic therapy cleared actinic keratoses and warty lesions on the hands of organ-transplant recipients better than blative fractional laser therapy alone in a randomized clinical trial. Ablative fractional laser-assisted photodynamic therapy was painful and caused intense inflammation in 30% of patients, but completely cleared 73% of all actinic keratoses and 37% of all wartlike lesions, compared with 31% and 14% respectively, for ablative fractional laser alone.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ